The two companies also collaborated with The Naomi Berrie Diabetes Center at Columbia University Medical Center, MedStar Diabetes Institute, and Duke Health’s Diabetes Program to gather a world class brain trust with deep clinical experience.
Bethesda, Maryland (PRWEB)
September 08, 2017
Mytonomy today announced that it has worked over the last six months on modern, culturally relevant microlearning patient education for new insulin users in partnership with Sanofi. The collaboration marries Sanofi’s work in putting patients at the center of care delivery and research in type 2 diabetes with Mytonomy’s state of the art patient experience cloud and modern learning science to help deliver better outcomes, higher levels of engagement and improved patient experience.
The two companies also collaborated with The Naomi Berrie Diabetes Center at Columbia University Medical Center, MedStar Diabetes Institute, and Duke Health’s Diabetes Program to gather a world class brain trust with deep clinical experience. These three preeminent diabetes education programs, plus Mytonomy and Sanofi focused on understanding the educational gaps in longitudinal activation of three of the fastest growing patient populations with type 2 diabetes who are new to insulin use – African American / Black, South Asian, and Hispanic / Latino patients. A new kind of patient education was created based on primary patient interviews and combined clinical experience.
Mytonomy’s Patient Experience Cloud is being used to deliver this unique content in a three site IRB (Institutional Review Board) approved clinical research study. To date, patient usage of the content delivered through Mytonomy’s Patient Experience Cloud software platform are extraordinarily high across all demographics, a range of literacy levels, ethnicities, races and age. The study is due to be completed by Q4 2017 with results that will be presented by the three participating healthcare system sites.
“This endeavor represents Sanofi’s commitment to developing solutions that fit into patients’ lives to help them better manage their medical conditions. Working with Mytonomy’s data platform holds tremendous promise for our ability to understand and address the needs of all people living with diabetes including those most at…